MARKET

CDNA

CDNA

Caredx
NASDAQ
19.20
-0.28
-1.44%
After Hours: 19.20 0 0.00% 17:24 12/29 EST
OPEN
19.55
PREV CLOSE
19.48
HIGH
19.56
LOW
18.92
VOLUME
443.34K
TURNOVER
--
52 WEEK HIGH
25.95
52 WEEK LOW
10.96
MARKET CAP
987.51M
P/E (TTM)
23.83
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CDNA last week (1222-1226)?
Weekly Report · 20h ago
CareDx Awards Inducement RSUs to 39 New Employees Under 2025 Equity Plan
Reuters · 3d ago
CAREDX ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 3d ago
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Barchart · 3d ago
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)
Seeking Alpha · 12/22 15:15
Weekly Report: what happened at CDNA last week (1215-1219)?
Weekly Report · 12/22 09:19
CareDx Wins Preliminary Court Approval for Derivative Settlement
TipRanks · 12/18 22:34
CAREDX INC: SHALL ENGAGE OUTSIDE COUNSEL BY NO LATER THAN END OF Q1 OF 2026
Reuters · 12/18 22:00
More
About CDNA
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.